Close Menu

NEW YORK (360Dx) – Qiagen said today that it has signed a non-exclusive partnership deal with Tecan Group to improve the processing of Qiagen's QuantiFeron-TB Gold Plus (QFT-Plus) diagnostic test.

Specifically, the companies are working together to standardize and automate the manual steps in liquid handling for the aliquoting of QFT-Plus samples using Tecan's Fluent laboratory automation workstation and Lithium Heparin single-tube workflow.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.